Leader in GI Patient Care, Education, and Research Duke GI on LinkedIn: https://xitter.cf/t.co/r4uPeWSPBH

Durham, North Carolina
Joined September 2014
🔔As @AmreenDinani said: “ if you can’t keep your liver healthy, you can t keep the rest of your organs healthy🫀” Read this to learn more from the MASLD expert 👇🏻 #MASLD #liver @Duke_GI_ @dukemedicine
Can improving liver health help protect the heart? Duke GI researcher @AmreenDinani leads a novel clinical trial studying whether Resmetirom can impact both MASH & heart failure, helping redefine metabolic disease as a whole-body condition. #MASH #HFpEF du.ke/p/h5kh
1
3
432
Duke GI retweeted
Congratulations! Love to see APPs in leadership
1
1
503
Duke GI retweeted
Congratulations! So well deserved and what a trend setter. Hope to see other programs promote their incredible APPs
1
2
576
Histologically normal liver was associated with better survival and lower recurrence after hepatic resection for HCC than both cirrhotic and diseased non-cirrhotic liver. These findings challenge the conventional cirrhotic/non-cirrhotic classification. doi.org/10.1097/LVT.00000000…
9
1
19
1,161
Duke GI retweeted
Hepatitis B Foundation@HepBFoundationJul 13
Hepatitis B disproportionately affects Asian and African immigrants in the U.S. During #MinorityMentalHealthMonth, let’s highlight the importance of mental health while managing chronic conditions such as hepatitis B. 👉 hepb.org/blog/minority-healt… #HepatitisB #MentalHealthMatters
3
5
292
From our July newsletter: Researchers sought to characterize the timing and predictors of early-onset and late-onset #depression among adults with #GIcancer. Explore the full study in @JournalofGISurg: ow.ly/PBH650ZlbMP
1
1
4
1,024
Save the date: Duke Medical Alumni Weekend is Nov. 13–15, 2026. Reconnect with classmates, celebrate reunion milestones, attend Breakfast with the Dean, Medicine Grand Rounds, class gatherings, and more. Registration opens in September. 🔗 Learn more: medschool.duke.edu/about-us/…
2
3
605
Duke GI retweeted
📝 JAMA Review: #AlcoholRelatedLiverDisease is the leading cause of #liver-related #mortality and the most common indication for liver #transplant in Europe and the US, with mortality rates rising over the past two decades. ALD develops with chronic daily #alcohol consumption (>20 g/d for women, >30 g/d for men) and encompasses reversible #steatosis, #steatohepatitis, #fibrosis, #cirrhosis, and #hepatocellular #carcinoma. 🔗 ja.ma/4eVgvZK
4
103
6
263
33,041
Thankful to have been a part of this cohort. Great opportunity to connect and make progress in the field of GI. @ASGEendoscopy @Duke_GI_
Ready to lead the future of GI care? Only a select group will help shape the future of artificial intelligence in gastroenterology. Will you be one of them? Now is your chance to join an exclusive group of AI Scholars collaborating with world-renowned mentors on groundbreaking projects driving the next wave of AI-powered care, research and discovery. Applications now open through June 30. hubs.ly/Q04lrcjF0 #AI #GIEndoscopy #Endoscopy #Gastroenterology #AIGI #GIInnovation #ArtificialIntelligence #MedicalInnovation #GITwitter
2
1
8
776
Cellular therapies are showing tremendous promise for certain cancers previously thought to be incurable. DCI's Diane Reidy-Lagunes, MD, and Chenyu Lin, MD, discuss how they work and what the future may hold. duke.is/g/2wps @DukeHealth | @DukeMedSchool
1
5
9
663
Thank you to everyone that joined us at #LICOP night out yesterday! 🫶 If you missed please come join us at room 153B for our annual meeting!
2
6
404
Standing ovation at ASCO in the middle of the plenary session Finally some hope for people living with pancreatic cancer
Presented at #ASCO26: Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM @ASCO
1
2
11
2,358
Duke GI retweeted
BREAKING NEWS: A major milestone for people living with #HepatitisD. The FDA has approved #bulevirtide (#Hepcludex), the first approved treatment for chronic #HDV infection. In this news article, #AASLD member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV. Read more: bit.ly/4u70DJg.
15
1
38
7,596
Grateful to @APFEDorg for all of their amazing advocacy and support in recognition of World EoE Day...and everyday.
5
7
495
🎓 We're still celebrating! Congratulations to the 464 students from the Duke University School of Medicine who graduated on Sunday, May 10, 2026. 🔗 Read more about the numbers behind this year's graduates: medschool.duke.edu/news/grad…
6
1
15
975
Faculty, staff and residents from the Department of Medicine traded scrubs and laptops for hard hats this spring, partnering with Habitat for Humanity of Durham to help build affordable housing in the community we serve. 🏠💙 medicine.duke.edu/news/under…
1
5
271
The #DDW2026 Exhibit Hall is officially open! Join us in Hall F (Level 3) from 9:30 a.m. to 4 p.m. or during scientific session breaks each day from 9:30 a.m.–10 a.m., 11:30 a.m.–2 p.m., and 3:30 p.m.–4 p.m.
5
17
1,284
Don’t miss out on the AI Scholars Program presentations at @ASGEendoscopy learning center! @DDWMeeting @Duke_GI_
Join us at the ASGE learning center to learn the work of the AI Scholars! Working towards AI 🤖Human Interaction 🤝 #ASGE #DDW26
1
1
3
333
How does MASLD link to HFpEF? Our data point to mitochondrial energy metabolism and kidney-related metabolites as key connections—and potential biomarkers. Full text: rdcu.be/ffW0W @SvatiShah @CindyMoylan_MD
3
9
539
LCongratulations to Roper Lab undergraduate students Vyom Patel and Sahil Choudhri on completing their senior honors theses.
1
1
4
809